pmc logo image
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors

Formats:

Ann Rheum Dis. 1989 April; 48(4): 312–316.
PMCID: PMC1003747
A study of headaches and migraine in Sjögren's syndrome and other rheumatic disorders.
B Pal, C Gibson, J Passmore, I D Griffiths, and W C Dick
Department of Rheumatology, Royal Victoria Infirmary, Newcastle upon Tyne.
Abstract
Migraine occurs with increased frequency in patients with systemic lupus erythematosus and in subjects suffering from Raynaud's phenomenon without any underlying connective tissue disorders. A possible link between migraine and Raynaud's phenomenon has been suggested. Two rheumatic conditions where Raynaud's phenomenon occurs very commonly are scleroderma and primary Sjögren's syndrome. It is possible that migraine is also common in these disorders but has been unrecognised. Therefore, the prevalence of migraine was assessed by a questionnaire in 191 subjects suffering from various connective tissue disorders and control subjects. Migraine was diagnosed in 16/35 (46%) patients with primary Sjögren's syndrome, 31/97 (32%) patients with scleroderma, 4/33 (12%) patients with rheumatoid arthritis/Sjögren's syndrome compared with 3/26 (11%) control subjects. A family history of headaches was more common in the patient groups than controls. There was a significant association between occurrence of Raynaud's phenomenon and migraine. Small vessel pathology may underlie both migraine and Raynaud's phenomenon in these connective tissue disorders--as has been suggested in systemic lupus erythematosus. The findings stress the need to ask specifically about complaints of headaches/migraines in patients with scleroderma and primary Sjögren's syndrome for the appropriate total management of these patients.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (701K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Isenberg DA, Meyrick-Thomas D, Snaith ML, McKeran RO, Royston JP. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis. 1982 Feb;41(1):30–32. [PubMed]
  • Zahavi I, Chagnac A, Hering R, Davidovich S, Kuritzky A. Prevalence of Raynaud's phenomenon in patients with migraine. Arch Intern Med. 1984 Apr;144(4):742–744. [PubMed]
  • Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. J Invest Dermatol. 1983 May;80(5):386–391. [PubMed]
  • Whaley K, Williamson J, Chisholm DM, Webb J, Mason DK, Buchanan WW. Sjogren's syndrome. I. Sicca components. Q J Med. 1973 Apr;42(166):279–304. [PubMed]
  • ROPES MW, BENNETT GA, COBB S, JACOX R, JESSAR RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed]
  • Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Théroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med. 1981 Mar 26;304(13):763–766. [PubMed]
  • Hughes GR. Central nervous system lupus--diagnosis and treatment. J Rheumatol. 1980 May–Jun;7(3):405–411. [PubMed]
  • Brandt KD, Lessell S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum. 1978 Jan–Feb;21(1):7–16. [PubMed]